Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation

Journal of Heart Valve Disease

Volumn 17, Issue 4, 2008, Pages 402-412

  Disatian, Sirilak ^a   Ehrhart III, E J ^a   Zimmerman, Sarah ^a   Orton, E Christopher ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CARDIAC MYOSIN; CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; COLLAGENASE 3; DESMIN; INTERSTITIAL COLLAGENASE; KI 67 ANTIGEN; MYOSIN; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOLOGY; DEGENERATIVE DISEASE; DISEASE SEVERITY; FEMALE; GENETIC TRANSFORMATION; HEART MUSCLE CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYME CELL; MITRAL VALVE DISEASE; MYOFIBROBLAST; MYXOMATOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION;

ANIMALS; CELL TRANSDIFFERENTIATION; DOG DISEASES; DOGS; FEMALE; HEART VALVE DISEASES; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MITRAL VALVE; PHENOTYPE;

EID: 50249092065     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Devereux RB. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995;10:107-116
2. Fontana ME, Sparks EA, Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Curr Probl Cardiol 1991;16:309-375
3. King BD, Clark MA Baba N, Kilman JW, Wooley CF. 'Myxomatous' mitral valves: Collagen dissolution as the primary defect. Circulation 1982;66:288-296
4. Kogure K. Pathology of chronic mitral valvular disease in the dog. Jpn J Vet Sci 1980;42:323-335
5. Braunwald E. Valvular heart disease. In: Braunwald E (ed.), Heart disease. A Textbook of Cardiovascular Medicine, 5th edn. WB Saunders, Philadelphia, 1997:1007-1072
6. Devereux RB. Mitral valve prolapse and severe mitral regurgitation. Circulation 1988;78:234-236
7. Savage DD, Devereux RB, Garrison RJ, et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: The Framingham Study. Am Heart J 1983;106:577-578
8. Levy D, Savage DD. Prevalence and clinical features of mitral valve prolapse. Am Heart J 1963;113:1281
9. Guy FC, MacDonald RPR, Fraser DB, Smith ER. Mitral valve prolapse as a cause of hemodynamically important mitral regurgitation. Can J Surg 1980;23:166-170
10. Buchanan JW. Prevalence of cardiovascular disorders. In: Fox PR, Sisson D, Moise NS (ed.), Textbook of Canine and Feline Cardiology, 2nd edition. WB Saunders, Philadelphia, 1999:457-470
11. Delweiler DK, Patterson DF. The prevalence and types of cardiovascular disease in dogs. Ann N Y Acad Sci 1965;127:481-516
12. Pedersen HD, Haggstrom J. Mitral valve prolapse in the dog: A model of mitral valve prolapse in man. Cardiovasc Res 2000;47:234-243
13. Pomerance A, Whitney JC. Heart valve changes common in man and dog: A comparative study. Cardiovasc Res 1970;4:61-66
14. Pensinger RR. Comparative aspects of mitral valve disease in dogs. Ann N Y Acad Sci 1965;118:525-534
15. Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can J Cardiol 1996;12:231-236
16. Dreger SA, Taylor PM, Allen SP, Allen SP, Yacoub MH. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves. J Heart Valve Dis 2002;11:875-880
17. Taylor PM, Batten P, Brand NJ, Thomas PS, Yacoub MH. The cardiac valve interstitial cell. International J Biochem Cell Biol 2003;35:113-118
18. Rabkin E, Aikawa M, Stone JR, Fukumoto Y, Libby P, Scheon FJ. Activated interstitial myofibroblasts express catabolic enzymes and mediate matrix remodeling in myxomatous heart valves. Circulation 2001;104:2525-2532
19. Rabkin E, Hoerstrup SP, Aikawa M, Mayer JE, Schoen FJ. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in-vitro maturation and in-vivo remodeling. J Heart Valve Dis 2002;11:308-314
20. Rabkin-Aikawa E, Farber M, Aikawa M, Schoen FJ. Dynamic and reversible changes of interstitial cell phenotype during remodeling of cardiac valves. J Heart Valve Dis 2004;13:841-847
21. Tamura K, Jones M, Yamada I, Ferrans VJ. Wound healing in the mitral valve. J Heart Valve Dis 2000;9:53-63
22. Durbin AD, Gotlieb AI. Advances towards understanding heart valve response to injury. Cardiovasc Pathol 2002;11:69-77
23. Messier RH, Bass BL, Aly HM, et al. Dual structural and functional phenotypes of the porcine aortic valve interstitial population: Characteristics of the leaflet myofibroblast. J Surg Res 1994;57:1-21
24. Black A, French AT, Dukes-McEwan J, Corcoran BM. Ultrastructural morphologic evaluation of the phenotype of valvular interstitial cells in dogs with myxomatous degeneration of the mitral valve. Am J Vet Res 2005;66:1408-1414
25. Paranya G, Vineberg S, Dvorin E, et al. Aortic valve endothelial cells undergo transformation growth factor-β-mediated and non-transforming growth factor-β-mediated transdifferentiation in vitro. Am J Pathol 2001;159:1335-1343
26. Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998;83:1015-1026
27. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710-1715
28. Giles BR, Balachandran K, Sucosky P, Yoganathan AP. Site-specific biological responses of porcine aortic valve to cyclic stretch. Proceedings, Fourth Biennial Meeting of The Society for Heart Valve Disease 2007:110
29. Weston MW, Yoganathan AP. Biosynthetic activity in heart valve leaflets in response to in vitro flow environments. Ann Biomed Eng 2001;29:752-763
30. Merryman WD, Youn I, Lukoff HD, et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: Implications for collagen synthesis. Am J Physiol 2006;290: H224-H231
31. Kershaw JD, Misfeld M,, Sievers HH, Yacoub MH, Chester AH. Specific regional and directional contractile responses of aortic cusp tissue. J Heart Valve Dis 2004;13:798-803
32. Merryman WD, Haung HYS, Scheon FJ, Sacks MS. The effects of cellular contraction on aortic valve leaflet flexural stiffness. J Biomech 2006;39:88-96
33. Leask RL, Jain N, Butany J. Endothelium and valvular diseases of the heart. Microsc Res Tech 2003;60:129-137
34. Corcoran BM, Black A, Anderson H, et al. Identification of surface morphologic changes in the mitral valve leaflets and chordae tendineae of dogs with myxomatous degeneration. Am J Vet Res 2004;65:198-206
35. Stein PD, Wang CH, Riddle JM, et al. Scanning electron microscopy of operatively excised severely regurgitant floppy mitral valves. Am J Cardiol 1989;64:392-394